carbostyril has been researched along with Eye Burns in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q; Wu, X; Xin, M | 1 |
| Ciftci, F; Eyuboglu, S; Sahan, B; Yaba, A; Yalvac, BI; Yilmaz, B | 1 |
2 other study(ies) available for carbostyril and Eye Burns
| Article | Year |
|---|---|
Strengthened rebamipide ocular nanoformulation to effectively treat corneal alkali burns in mice through the HMGB1 signaling pathway.
Topics: Alanine; Animals; Antioxidants; Blotting, Western; Burns, Chemical; Chickens; Chorioallantoic Membrane; Disease Models, Animal; Drug Carriers; Enzyme-Linked Immunosorbent Assay; Epithelium, Corneal; Eye Burns; Glycyrrhizic Acid; HMGB1 Protein; Humans; Mice; Ophthalmic Solutions; Quinolones; Rabbits; Signal Transduction; Sodium Hydroxide; Wound Healing | 2021 |
Comparison of the Effects of Dovitinib and Bevacizumab on Reducing Neovascularization in an Experimental Rat Corneal Neovascularization Model.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Benzimidazoles; Bevacizumab; Burns, Chemical; Corneal Neovascularization; Disease Models, Animal; Eye Burns; Female; Ophthalmic Solutions; Quinolones; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2019 |